Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dyslipidemias: early-phase trial registry
12 of 29 indexed Dyslipidemias trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #552 of 28,707 conditions by registered trial count.
29 US clinical trials · 12 currently recruiting · #552 of 28,707 conditions by registered trial count
Dyslipidemias: 29 US clinical trials tracked, 12 recruiting.
Dyslipidemias is the subject of 29 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is University of Hawaii, running 2 of these trials.
Enrollment posture brief
Registry condition dyslipidemias
OPEN 12 | RECR 41% | LATE 2 | EARLY 9 | RANK #552 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Exercise (41% recruiting · 58 trials)
Dyslipidemias lists 12 open slots (41% of 29 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dyslipidemias on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dyslipidemias recruits in line with its size-band peers.
12 of 29 indexed trials (41.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Dyslipidemias trials is spread across many organizations.
University of Hawaii accounts for 2 of 29 trials (6.9%). 26 distinct sponsors appear on at least one study for this condition label.
-
Typical Dyslipidemias enrolment sits around 85 participants.
Median target enrolment is 85 among the 29 trials that report a genuine target (sentinel values excluded). 16 of those (55.2%) plan for fewer than 100 participants.
-
Dyslipidemias research is mostly interventional.
25 interventional and 4 observational studies make up this index (86.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
29 total, page 1 of 1
'Ai Pono Cooking Demonstrations
University of Hawaii
NCT06526650
Military Health and Nutrition Examination Study
Pennington Biomedical Research Center
NCT06380322
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Brigham and Women's Hospital
NCT06300450
Gut Microbiota in Metabolic Surgery
Vanderbilt University Medical Center
NCT05000996
PILI 'Āina Household
University of Hawaii
NCT06526273
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
Duke University
NCT05129345
Dietary Supplementation on Body Fat Composition
Brightseed
NCT06296251
Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
University of Connecticut
NCT05700916
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Priscilla Hsue, MD
NCT05488431
Dose Response Effects of Pecan Consumption
University of Georgia
NCT05949879
Cottonseed Oil Dose Response
University of Georgia
NCT05686954
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
NewAmsterdam Pharma
NCT06496243
The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older
University of Illinois at Chicago
NCT05654142
Causal Mechanisms in Adolescent Arterial Stiffness
Baylor College of Medicine
NCT04128969
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
Loma Linda University
NCT06159543
Study of ARO-APOC3 in Adults With Dyslipidemia
Arrowhead Pharmaceuticals
NCT05413135
Medically Tailored Groceries and Food Resource Coaching
University of Texas Southwestern Medical Center
NCT06242808
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
University of California, San Francisco
NCT03207945
A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations
Johns Hopkins University
NCT04696653
Evaluation of a Lifestyle Medicine Practice
Ohio University
NCT03739034
Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)
Silence Therapeutics
NCT04606602
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
Eli Lilly and Company
NCT02714569
A Study of LY3475766 in Healthy Participants
Eli Lilly and Company
NCT04052594
Developing an Adaptive Lifestyle Intervention Program in Family Medicine Clinics
University of Alabama at Birmingham
NCT04392284
12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women
Pusan National University
NCT04014686
Zinc Supplement Before or With Food in Generally Healthy Men
UCSF Benioff Children's Hospital Oakland
NCT03619421
Effects of Psyllium on Niacin Tolerability
VA Greater Los Angeles Healthcare System
NCT03370848
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
Catabasis Pharmaceuticals
NCT01968720
Production of Free Fatty Acids From Blood Triglycerides
Mayo Clinic
NCT00911482
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 5 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Dyslipidemias records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dyslipidemias trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dyslipidemias page
29 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 12 Dyslipidemias trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Hawaii sponsors the most Dyslipidemias trials on record, review their full trial history before evaluating a specific study. See University of Hawaii's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dyslipidemias condition card totals 29 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.